Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

T. Rowe Price Group, Inc. (TROW), Janus Capital Group Inc (JNS): Mutual Fund Companies Make Good Investments Too

Page 1 of 2

Millions of investors use mutual funds for retirement or to pay for college tuition. What many of them don’t realize is that the mutual fund companies themselves are publicly traded companies that can be invested in too.

Some of them make compelling investments. Despite the lower management fees and the presence of alternative lower-cost options like ETFs, mutual fund money management remains a multi-trillion dollar industry. As long as people keep saving, there’s money to be made. Several mutual fund companies that currently make enticing investment opportunities are names that are familiar to most.

T. Rowe Price Group, Inc. (NASDAQ:TROW)

T. Rowe Price Group, Inc.

T. Rowe Price Group, Inc. (NASDAQ:TROW) managed roughly $90 billion in its family of mutual funds. The company has one of the longest histories in the investment industry, having been founded in 1937.

Price has seen its managed assets under threat from ETFs, but it hopes to counter that by launching its own line of ETFs. It remains to be seen how effective this strategy will be, but attempting to establish a presence in this growing space seems like a good idea.

From a fundamental standpoint, its P/E of 18 and price-to-book ratio of 4.8 are a little on the rich side. But, analysts have been raising earnings and revenue expectations, and operating margins continue to be among the highest in the industry.

If you like stocks with a solid growing dividend, you’ll love Price. This company has been growing its dividend for decades and now sports a yield of almost 2%.

Janus Capital Group Inc (NYSE:JNS)

Janus Capital Group Inc (NYSE:JNS) is primarily an equity-based mutual fund company, and as such has experienced some difficulty in growing assets under management in the past decade. Currently, the company manages around $160 billion.

This company doesn’t have the growth potential of some of the other stocks on this list — the forecast five-year growth rate is just 10% — but its value characteristics alone make it worth a look. It maintains a price-to-book ratio of just 1.1, and its P/E ratio of 11 is compelling. If the stock market continues its bull run and the mountain of cash on the sidelines begins moving back into equities, this entry point could end up looking downright cheap. In the meantime, shareholders can enjoy a 3.2% dividend yield while they wait for growth to develop.

Franklin Resources, Inc. (NYSE:BEN)

Franklin Resources manages just under $1 trillion through the Franklin Templeton group of funds. The company specializes in fixed income offerings and its earnings and stock price have done very well lately. In the last 12 months, the stock price has risen from around $100 to $160.

Analysts have also been raising their earnings estimates in the past couple of months. They’re now projecting current year earnings of about $10.42 per share – up from estimates of $9.98 just two months ago. Add in projected five year growth of about 15% and a reasonable P/E ratio of 14 and you’ve got a stock that still has some room to run.

AllianceBernstein Holding LP (NYSE:AB)

AllianceBernstein Holding manages nearly a half trillion dollars. On the surface, this stock looks attractive based on its yield alone. Currently, the stock is yielding roughly 6% which puts it well above the average of its investment management group peers. The trouble? The quarterly dividend payout is erratic. The quarterly payout has been bouncing up and down for much of the last decade. The current yield may be 6% but there’s certainly no guarantee that you’re going to see that going forward.

The stock price has doubled in the last 12 months leaving some fearing that the stock is overbought, but current P/E and price-to-book ratios remain reasonable; there could be more upward potential yet.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!